NATIONAL

Pfizer Says COVID-19 Pill Cut Hospital, Death Risk By 90%

0
FILE - This 2020 electron microscope image provided by the National Institute of Allergy and Infectious Diseases - Rocky Mountain Laboratories shows SARS-CoV-2 virus particles which cause COVID-19, isolated from a patient in the U.S., emerging from the surface of cells cultured in a lab. Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections. The company announced Friday, Nov. 5, 2021 it will soon ask the U.S. Food and Drug Administration and international regulators to authorize its pill, which is taken twice a day for five days. (NIAID-RML via AP)

(AP) — Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections. The company announced Friday it will soon ask the U.S. Food and Drug Administration and international regulators to authorize its pill, which is taken twice a day for five days. A similar pill from competitor Merck is currently under FDA review and was cleared Thursday by U.K. regulators. Drugmakers around the world have been racing to develop an easy-to-use pill to blunt the effects of COVID-19. All therapies now authorized in the U.S. require an IV or injection.

AAA Texas: Statewide Average Gas Price Up Three Cents From Last Week

Previous article

US Employers Shrugged Off Virus And Stepped Up Hiring

Next article

You may also like

More in NATIONAL